<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">


Adult & Child Center for Outcomes Research and Delivery Science


First RSV antibody treatment to protect all infants approved in the U.S.

Written by Washington Post on August 18, 2023

The shot provides vaccine-like protection to healthy babies during a single winter respiratory virus season. But Sean O’Leary, a pediatric infectious-disease specialist at Children’s Hospital Colorado, said he expected logistical, educational and possible financial hurdles that could delay the drug’s rollout before this year’s winter respiratory virus season.

Topics: Press Coverage


Related Stories